UY26680A1 - Inhibidor del intercambiador de sodio-hidrógeno de tipo 1. - Google Patents

Inhibidor del intercambiador de sodio-hidrógeno de tipo 1.

Info

Publication number
UY26680A1
UY26680A1 UY26680A UY26680A UY26680A1 UY 26680 A1 UY26680 A1 UY 26680A1 UY 26680 A UY26680 A UY 26680A UY 26680 A UY26680 A UY 26680A UY 26680 A1 UY26680 A1 UY 26680A1
Authority
UY
Uruguay
Prior art keywords
inhibitor
sodium
type
hydrogen exchanger
nhe
Prior art date
Application number
UY26680A
Other languages
English (en)
Spanish (es)
Inventor
Weichao George Chen
Eric David Cox
Angel Guzman-Perez
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of UY26680A1 publication Critical patent/UY26680A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/4709Non-condensed quinolines and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Treatment Of Water By Ion Exchange (AREA)
  • Preventing Corrosion Or Incrustation Of Metals (AREA)
  • Plural Heterocyclic Compounds (AREA)
UY26680A 2000-04-28 2001-04-24 Inhibidor del intercambiador de sodio-hidrógeno de tipo 1. UY26680A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US20043200P 2000-04-28 2000-04-28

Publications (1)

Publication Number Publication Date
UY26680A1 true UY26680A1 (es) 2001-12-28

Family

ID=22741697

Family Applications (1)

Application Number Title Priority Date Filing Date
UY26680A UY26680A1 (es) 2000-04-28 2001-04-24 Inhibidor del intercambiador de sodio-hidrógeno de tipo 1.

Country Status (40)

Country Link
EP (1) EP1276737A1 (ko)
JP (1) JP2003531900A (ko)
KR (1) KR20020093079A (ko)
CN (1) CN1225466C (ko)
AP (1) AP2002002651A0 (ko)
AR (1) AR028375A1 (ko)
AU (1) AU2001235896A1 (ko)
BG (1) BG107139A (ko)
BR (1) BR0110268A (ko)
CA (1) CA2407535A1 (ko)
CO (1) CO5221125A1 (ko)
CR (1) CR6797A (ko)
CZ (1) CZ20023408A3 (ko)
DZ (1) DZ3310A1 (ko)
EA (1) EA004882B1 (ko)
EE (1) EE200200615A (ko)
GT (1) GT200100064A (ko)
HN (1) HN2001000042A (ko)
HR (1) HRP20020851A2 (ko)
HU (1) HUP0300651A2 (ko)
IL (1) IL152075A0 (ko)
IS (2) IS6567A (ko)
MA (1) MA26897A1 (ko)
MX (1) MXPA02010600A (ko)
MY (1) MY133842A (ko)
NO (1) NO20025132L (ko)
NZ (1) NZ521348A (ko)
OA (1) OA12256A (ko)
PA (1) PA8513301A1 (ko)
PE (1) PE20011270A1 (ko)
PL (1) PL357765A1 (ko)
SK (1) SK14872002A3 (ko)
SV (1) SV2002000418A (ko)
TN (1) TNSN01065A1 (ko)
TR (1) TR200202439T2 (ko)
UA (1) UA73348C2 (ko)
UY (1) UY26680A1 (ko)
WO (1) WO2001083470A1 (ko)
YU (1) YU79602A (ko)
ZA (1) ZA200208605B (ko)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA03006872A (es) * 2001-01-31 2003-11-13 Pfizer Prod Inc Etanolatos del inhibidor del intercambiador de sodio-hidrogeno de tipo 1.
CA2469305A1 (en) * 2001-12-19 2003-06-26 Frank Robert Busch Methods for preparing sodium-hydrogen exchanger type-1 inhibitors
EP1499317A1 (en) * 2002-05-02 2005-01-26 Pfizer Products Inc. Treatment of diabetes and diabetic complications with nhe-1 inhibitors
FR2840302B1 (fr) * 2002-06-03 2004-07-16 Aventis Pharma Sa Derives d'isoindolones, procede de preparation et intermediaire de ce procede a titre de medicaments et compositions pharmaceutiques les renfermant
ES2220185B1 (es) * 2002-07-16 2006-04-01 Consejo Sup. De Investig. Cientificas Nuevo peptido inhibidor del intercambiador na+/h+ (pinhe), y sus aplicaciones.
US7550480B2 (en) * 2003-02-14 2009-06-23 Smithkline Beecham Corporation Compounds
RU2518741C1 (ru) * 2013-03-22 2014-06-10 Федеральное государственное автономное образовательное учреждение высшего профессионального образования "ЮЖНЫЙ ФЕДЕРАЛЬНЫЙ УНИВЕРСИТЕТ" СРЕДСТВО, ИНГИБИРУЮЩЕЕ Na+/H+-ОБМЕН, И ГАЛОГЕНИДЫ 1-ДИАЛКИЛАМИНОЭТИЛ-3-[ЗАМЕЩЕННЫЙ(ДИЗАМЕЩЕННЫЙ) ФЕНАЦИЛ]-2-АМИНОБЕНЗИМИДАЗОЛИЯ

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1056729B1 (en) * 1998-02-27 2004-12-29 Pfizer Products Inc. N-[(substituted five-membered di- or triaza diunsaturated ring)carbonyl]guanidine derivatives for the treatment of ischemia

Also Published As

Publication number Publication date
EA200201023A1 (ru) 2003-02-27
MA26897A1 (fr) 2004-12-20
YU79602A (en) 2006-05-25
ZA200208605B (en) 2003-10-24
OA12256A (en) 2003-11-06
AU2001235896A1 (en) 2001-11-12
UA73348C2 (en) 2005-07-15
GT200100064A (es) 2002-03-22
IL152075A0 (en) 2003-05-29
HRP20020851A2 (en) 2005-02-28
CR6797A (es) 2004-05-17
EP1276737A1 (en) 2003-01-22
TR200202439T2 (tr) 2003-02-21
SK14872002A3 (sk) 2004-03-02
CN1225466C (zh) 2005-11-02
PA8513301A1 (es) 2003-09-05
NZ521348A (en) 2004-09-24
EE200200615A (et) 2004-04-15
HN2001000042A (es) 2001-07-09
BG107139A (bg) 2003-07-31
DZ3310A1 (fr) 2001-11-07
WO2001083470A1 (en) 2001-11-08
CZ20023408A3 (cs) 2004-01-14
CA2407535A1 (en) 2001-11-08
CO5221125A1 (es) 2002-11-28
EA004882B1 (ru) 2004-08-26
NO20025132L (no) 2002-12-12
AP2002002651A0 (en) 2002-12-31
AR028375A1 (es) 2003-05-07
IS6588A (is) 2002-10-21
MY133842A (en) 2007-11-30
JP2003531900A (ja) 2003-10-28
BR0110268A (pt) 2003-12-30
MXPA02010600A (es) 2003-03-10
PE20011270A1 (es) 2001-12-12
HUP0300651A2 (hu) 2003-07-28
KR20020093079A (ko) 2002-12-12
IS6567A (is) 2002-09-24
SV2002000418A (es) 2002-07-03
TNSN01065A1 (fr) 2005-11-10
CN1426404A (zh) 2003-06-25
PL357765A1 (en) 2004-07-26
NO20025132D0 (no) 2002-10-25

Similar Documents

Publication Publication Date Title
PA8468401A1 (es) Compuestos para el tratamiento de la isquemia
GT199900150A (es) 1,2,3,4-tetrahidroquinolinas 2-sustituidas 4-carboxiamino sustituidas.
CO5271715A1 (es) 7-aza-indolin-2-onas sustituidas en 4 y su uso como inhibidores de proteiuna quinasa
SV2002000520A (es) Derivados de pirazol ref. pcs10927aajr/bb
UY26889A1 (es) Compuestos farmacéuticos
PA8586801A1 (es) Inhibidores de hiv-integrasa, composiciones farmaceuticas y metodos para su uso
AR018162A1 (es) Pirroles substituidos, composicion farmaceutica y el uso de los mismos para la preparacion de dicha composicion farmaceutica
UY27203A1 (es) Bencimidazoles útiles en el tratamiento de la disfunción sexual
AR030537A1 (es) Acidos quinolincarboxilicos y naftiridincarboxilico antibacterianos
UY26680A1 (es) Inhibidor del intercambiador de sodio-hidrógeno de tipo 1.
AR020563A1 (es) Compuestos (poli)tia-alquinoicos y sus derivados, composiciones que los incluyen y su utilizacion
GT199900113A (es) Inhibidores de las fkbp.
ES2182090T3 (es) Nuevos derivados de pirrol.
AR006675A1 (es) 4-benzoilisotiazoles herbicidas, procedimiento para obtenerlas, las composiciones herbicidas que las contienen y el procedimiento de aplicacionde dichos compuestos.
ES2175661T3 (es) Derivados de la isoflavona, procedimientos para la preparacion de los mismos y composiciones farmaceuticas que los contienen.
TR200201167T2 (tr) Sodyum-hidrojen değiştirici tip 1 önleyici kristalleri.
UY26417A1 (es) Cristales de inhibidor del intercambiador de sodio-hidrógeno tipo 1
BR0005122A (pt) Método para a preparação de inibidor de permutador de sódio-hidrogênio do tipo 1
DOP2003000569A (es) Composiciones farmaceuticas de mesilato de zoniporida y procedimiento para mejorar la solubilidad de la zoniporida
AR006676A1 (es) 4-benzoilisotiazoles herbicidas, procedimiento para obtenerlos, las composiciones herbicidas que los contienen y el procedimiento de aplicacion dedichos compuestos.
AR013306A1 (es) 4-benzoilisotiazoles herbicidas, procedimiento para obtenerlos, las composiciones herbicidas que los contienen y el procedimiento de aplicacion dedichos compuestos.
ECSP003742A (es) Cristales de inhibidor del intercambiador de sodio-hidrogeno tipo i
ES2062940B1 (es) Agente gastrocinetico, proceso para su preparacion y composiciones farmaceuticas que lo contengan.
HN2002000058A (es) Inhibidores de la pcp del tipo de acidos 3-heterociclilpropanohidroxamicos
DK1119351T3 (da) Anvendelse af katecholderivater som proteinaseinhibitorer

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20130819